URGN UroGen Pharma Ltd.

$50.32 -7.33%

49,383 Shares Traded
109,746 Average Volume (last 30 days)

as of March 23, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $535.74 thousand
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-40.53%
If Intiated One Month Ago, Shorts Have Realized a Return of:-8.6%
If Initiated Five Days ago, Shorts Have Realized a Return of:-0.2%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bullish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 0.98%
Short Interest134.61 thousand
Float13.75 million
Short Ratio1.09
Market Cap$746.7 million
Market Maker ActivityDaily Short Volume


Institutional Top Ideas Series: Consonance Capital (SeekingAlpha)
Urogen Pharma's (URGN) CEO Ron Bentsur on Q4 2017 Results - Earnings Call Transcript (SeekingAlpha)
Key events next week - healthcare (SeekingAlpha)
UroGen Pharma misses by $0.12 (SeekingAlpha)
More premarket analyst action - healthcare (SeekingAlpha)
Premarket analyst action - healthcare (SeekingAlpha)
UroGen Pharma beats by $0.03, beats on revenue (SeekingAlpha)
Stocks to watch next week (SeekingAlpha)
UroGen's MitoGel Fast Track'd in U.S. for urothelial carcinoma; shares up 3% (SeekingAlpha)
UroGen Pharma reports Q2 results (SeekingAlpha)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 35.3%

Earnings Stats

PE Ratio
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $33.6
50 Day Moving Average $50.84
52 Week High $58.66
52 Week Low $13.01

Data provided for free by IEX. Questions? Read the FAQ